| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR326 |
|
microRNA 326
|
|
|
0.560 |
0.731 |
| IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |
| FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
| DNASE1 |
P24855
|
deoxyribonuclease 1
|
|
7.0E-21 |
0.505 |
0.846 |
| MMP3 |
P08254
|
matrix metallopeptidase 3
|
Enzyme
|
5.7E-15 |
0.408 |
0.885 |
| GZMB |
P10144
|
granzyme B
|
Enzyme
|
3.7E-14 |
0.453 |
0.808 |
| BLK |
P51451
|
BLK proto-oncogene, Src family tyrosine kinase
|
Kinase
|
8.3E-14 |
0.585 |
0.769 |
| BANK1 |
Q8NDB2
|
B cell scaffold protein with ankyrin repeats 1
|
|
4.8E-12 |
0.653 |
0.538 |
| HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
| RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
| CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
| AIM2 |
O14862
|
absent in melanoma 2
|
|
2.2E-09 |
0.521 |
0.769 |
| TLR2 |
O60603
|
toll like receptor 2
|
|
1.0E-06 |
0.361 |
0.923 |
| VDR |
P11473
|
vitamin D receptor
|
Nuclear receptor
|
1.7E-05 |
0.352 |
0.885 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |